1147peverolimus (eve) Treatment for Advanced G1-g2 Neuroendocrine Tumours (nets) in the Community Setting: Clinical Benefit Irrespective of Grade or Primary Tumour Site.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1093/annonc/mdu345.16

Topics

  • Presentations referencing similar topics